A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆(9)-tetrahydrocannabinol (THC) by vaporisation

BACKGROUND: Significant interest has emerged in the therapeutic and interactive effects of different cannabinoids. Cannabidiol (CBD) has been shown to have anxiolytic and antipsychotic effects with high doses administered orally. We report a series of studies conducted to determine the vaporisation...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Pharmacol Toxicol
Main Authors: Solowij, Nadia, Broyd, Samantha J, van Hell, Hendrika H, Hazekamp, Arno
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Technical Advance
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4274767/
https://ncbi.nlm.nih.gov/pubmed/25319497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2050-6511-15-58
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados